HANSON & DOREMUS INVESTMENT MANAGEMENT – iShares Biotechnology ETF Transaction History
HANSON & DOREMUS INVESTMENT MANAGEMENT portfolio value:
$567,000
portfolio value
HANSON & DOREMUS INVESTMENT MANAGEMENT quarter portfolio value change:
-0.57%
quarter
iShares Biotechnology ETF 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -7.27% | -380 shares | -48K | $116.96 | 4.84K |
| Q2 2022 | share | Decrease | -21.60% | -1.44K shares | -254K | $117.63 | 5.22K |
| Q1 2022 | share | Decrease | -1.72% | -117 shares | -167K | $130.3 | 6.66K |
| Q4 2021 | share | Increase | +1.92% | 128 shares | -40K | $153.76 | 6.78K |
| Q3 2021 | share | Decrease | -9.74% | -718 shares | 77K | $161.68 | 6.65K |
| Q2 2021 | share | Increase | +6.38% | 442 shares | -45K | $163.53 | 7.37K |
| Q1 2021 | share | Decrease | -0.43% | -30 shares | -11K | $150.43 | 6.93K |
| Q4 2020 | share | Decrease | -5.59% | -412 shares | 56K | $151.22 | 6.96K |
| Q3 2020 | share | Decrease | -5.19% | -404 shares | -64K | $135.12 | 7.37K |
| Q2 2020 | share | Decrease | -1.32% | -104 shares | 214K | $136.33 | 7.77K |
| Q1 2020 | share | Decrease | -8.85% | -765 shares | -193K | $107.35 | 7.88K |
| Q4 2019 | share | Increase | +0.83% | 71 shares | 189K | $120.01 | 8.64K |
| Q3 2019 | share | Decrease | -14.67% | -1.47K shares | -244K | $99.04 | 8.57K |
| Q2 2019 | share | Decrease | -2.06% | -211 shares | -50K | $108.52 | 10.05K |
| Q1 2019 | share | Decrease | -1.07% | -111 shares | 147K | $111.12 | 10.26K |
| Q4 2018 | share | Increase | +0.65% | 67 shares | -257K | $95.84 | 10.37K |
| Q3 2018 | share | 0.00% | 0 shares | 125K | $121.2 | 10.30K | |
| Q2 2018 | share | Increase | +0.79% | 81 shares | 40K | $109.12 | 10.30K |
| Q1 2018 | share | Decrease | -1.80% | -187 shares | -20K | $105.91 | 10.22K |
| Q4 2017 | share | Decrease | -1.84% | -195 shares | -68K | $105.94 | 10.41K |
| Q3 2017 | share | Decrease | -0.06% | -6 shares | 83K | $110.2 | 10.60K |
| Q2 2017 | share | Increase | +0.94% | 99 shares | 69K | $102.4 | 10.61K |
| Q1 2017 | share | Increase | +8.82% | 852 shares | 173.21K | $96.79 | 10.51K |
| Q4 2016 | share | Increase | +6.76% | 612 shares | -18.21K | $87.5 | 9.66K |
| Q3 2016 | share | Increase | +5.20% | 447 shares | 135K | $95.41 | 9.05K |
| Q2 2016 | share | Increase | +12.43% | 951 shares | 73K | $84.79 | 8.60K |
| Q1 2016 | share | Increase | +9.53% | 666 shares | -123K | $85.88 | 7.65K |